Utility of physiologically based modeling and preclinical in vitro/in vivo data to mitigate positive food effect in a BCS class 2 compound.
about
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model VerificationApplication of physiologically based absorption modeling to formulation development of a low solubility, low permeability weak base: mechanistic investigation of food effect.Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.Quantitative ADME proteomics - CYP and UGT enzymes in the Beagle dog liver and intestine.Predictive Performance of Physiologically Based Pharmacokinetic Models for the Effect of Food on Oral Drug Absorption: Current Status.
P2860
Utility of physiologically based modeling and preclinical in vitro/in vivo data to mitigate positive food effect in a BCS class 2 compound.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Utility of physiologically bas ...... ect in a BCS class 2 compound.
@ast
Utility of physiologically bas ...... ect in a BCS class 2 compound.
@en
type
label
Utility of physiologically bas ...... ect in a BCS class 2 compound.
@ast
Utility of physiologically bas ...... ect in a BCS class 2 compound.
@en
prefLabel
Utility of physiologically bas ...... ect in a BCS class 2 compound.
@ast
Utility of physiologically bas ...... ect in a BCS class 2 compound.
@en
P2093
P2860
P1433
P1476
Utility of physiologically bas ...... ect in a BCS class 2 compound.
@en
P2093
Binfeng Xia
Hefei Zhang
Jennifer Sheng
Shoufeng Li
Tsu-han Lin
Tycho Heimbach
P2860
P2888
P304
P356
10.1208/S12249-013-0018-2
P407
P577
2013-08-17T00:00:00Z
P5875
P6179
1024935771